Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Skinny jabs have taken the world by storm over the past few years, but a lot of people keep their decision to use them a ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

The former glamour model, 48, jetted abroad earlier this week to get several 'tweaks' to her sixth £10,000 facelift, including pinning back her ears and undergoing a minor eye lift.

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...